This trial compared the use of 0.5% ropivacaine with and without 1 : 200,000 epinephrine to 0.5% bupivacaine with 1 : 200,000 epinephrine as an agent for maxillary lateral incisor infiltration anaesthesia. Bupivacaine and ropivacaine are considered to be`long-lasting' anaesthetics. The authors studied anaesthetic efficacy and injection discomfort.
There is little published data on the use of ropivacaine in dentistry.
Ropivacaine is a pure l-isomer unlike bupivacaine, which is a racemic mixture of the d-and l-isomers. It is suggested that this relatively recent addition to the local anaesthetic armamentarium offers a number of benefits. Firstly, ropivacaine produces less cardiovascular toxicity than bupivacaine. Secondly, there is evidence in the medical literature that ropivacaine has some inherent vasoconstrictive action. It is well known that vasoconstriction increases efficacy in dental anaesthesia.
Here electrical pulp testing was used to assess anaesthesia and injection discomfort was measured using a 4-point pain scale.
The results showed no difference between solutions in the number of lateral incisor teeth that were successfully anaesthetised. However, the duration of pulpal anaesthesia was less for the plain ropivacaine solution Needle insertion  No pain  26  65  23  57  28  70  Severe pain  0  0  0  0  0  0  Needle placement  No pain  16  40  81  45  18  45  Severe pain  0  0  1  3  0  0  Solution deposition  No pain  9  23  7  17  1  3  Severe pain  0  0  0  0  8 The use of long-acting solutions such as ropivacaine and bupivacaine can be considered appropriate if they decrease post-operative pain following surgical procedures. However, this long-lasting effect is only apparent after regional block injections. Long-acting anaesthetics do not offer advantages over conventional solutions such as lidocaine with epinephrine during infiltration techniques. Indeed, in this study the mean duration of pulpal anesthesia was a little over 30 min for the epinephrinecontaining solutions. The fact that plain ropivacaine had a shorter duration of activity compared to the epinephrinecontaining ropivacaine solution suggests that for optimal action of this agent the addition of a vasoconstrictor is required. It seems that any inherent vasoconstrictive action of ropivacaine offers little benefit during intra-oral infiltration anaesthesia.
The authors suggest that future studies should investigate the efficacy of ropivacaine for inferior alveolar nerve block anaesthesia. This is a more appropriate model for assessing clinical effectiveness as long-acting solutions are only indicated in dentistry when performing regional block anaesthesia.
